1. Home
  2. IPSC vs FSEA Comparison

IPSC vs FSEA Comparison

Compare IPSC & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.56

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Logo First Seacoast Bancorp Inc.

FSEA

First Seacoast Bancorp Inc.

N/A

Current Price

$12.32

Market Cap

56.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IPSC
FSEA
Founded
2019
1890
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
56.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPSC
FSEA
Price
$0.56
$12.32
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
927.3K
5.2K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$113,337,000.00
$14,753,000.00
Revenue This Year
$1,590.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4122.69
29.53
52 Week Low
$0.34
$9.25
52 Week High
$1.38
$13.00

Technical Indicators

Market Signals
Indicator
IPSC
FSEA
Relative Strength Index (RSI) 52.80 56.83
Support Level $0.50 $11.91
Resistance Level $0.62 $12.42
Average True Range (ATR) 0.04 0.19
MACD 0.01 0.02
Stochastic Oscillator 55.62 51.08

Price Performance

Historical Comparison
IPSC
FSEA

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

Share on Social Networks: